[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Drugs For Osteoarthritis Pain Market Research Report 2023

March 2023 | 300 pages | ID: GA71A2F3B63CEN
Introspective Market Research

US$ 3,450.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Drugs For Osteoarthritis Pain Market Overview:
Global Drugs For Osteoarthritis Pain Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Drugs For Osteoarthritis Pain involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Scope of the Drugs For Osteoarthritis Pain Market
The Drugs For Osteoarthritis Pain Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Drugs For Osteoarthritis Pain Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Drugs For Osteoarthritis Pain Market helps user to make precise decision in order to expand their market presence and increase market share.

Impact of COVID-19 on Drugs For Osteoarthritis Pain Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Drugs For Osteoarthritis Pain market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Global Drugs For Osteoarthritis Pain Market Segmentation
Global Drugs For Osteoarthritis Pain Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;

By Type, Drugs For Osteoarthritis Pain market has been segmented into:
NSAIDs
Opioids
Viscosupplements
Corticosteroids
Others

By Application, Drugs For Osteoarthritis Pain market has been segmented into:
Hospital
Clinics
Household

Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Drugs For Osteoarthritis Pain market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Drugs For Osteoarthritis Pain market.

Top Key Players Covered in Drugs For Osteoarthritis Pain market are:

Merck
Cytori Therapeutics
Eli Lilly
Sanofi
Novartis International
Afferent Pharmaceuticals
Nuvo Research
Techfields Pharma
Astellas Pharma
Horizon Pharma
SantoSolve
Endo Pharmaceuticals Holdings
BioDelivery Sciences International
AbbVie
Winston Pharmaceuticals
Zynerba Pharmaceuticals
ICeutica
Iroko Pharmaceuticals
Regeneron Pharmaceuticals
Pfizer
Daiichi Sankyo
Johnson & Johnson
Abbott Laboratories
Yooyoung Pharmaceutical
CrystalGenomics
Abiogen Pharma

Objective to buy this Report:
1. Drugs For Osteoarthritis Pain analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Drugs For Osteoarthritis Pain market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
CHAPTER 1: INTRODUCTION

1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
1.5 Market Segmentation

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT

3.1 By Type
3.2 By Application

CHAPTER 4: MARKET LANDSCAPE

4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

CHAPTER 5: DRUGS FOR OSTEOARTHRITIS PAIN MARKET BY TYPE

5.1 Drugs For Osteoarthritis Pain Market Overview Snapshot and Growth Engine
5.2 Drugs For Osteoarthritis Pain Market Overview
5.3 NSAIDs
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 NSAIDs: Geographic Segmentation
5.4 Opioids
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Opioids: Geographic Segmentation
5.5 Viscosupplements
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Viscosupplements: Geographic Segmentation
5.6 Corticosteroids
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Corticosteroids: Geographic Segmentation
5.7 Others
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Others: Geographic Segmentation

CHAPTER 6: DRUGS FOR OSTEOARTHRITIS PAIN MARKET BY APPLICATION

6.1 Drugs For Osteoarthritis Pain Market Overview Snapshot and Growth Engine
6.2 Drugs For Osteoarthritis Pain Market Overview
6.3 Hospital
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospital: Geographic Segmentation
6.4 Clinics
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Clinics: Geographic Segmentation
6.5 Household
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Household: Geographic Segmentation

CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS

7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 Drugs For Osteoarthritis Pain Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Drugs For Osteoarthritis Pain Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 Drugs For Osteoarthritis Pain Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
7.2 MERCK
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
7.3 CYTORI THERAPEUTICS
7.4 ELI LILLY
7.5 SANOFI
7.6 NOVARTIS INTERNATIONAL
7.7 AFFERENT PHARMACEUTICALS
7.8 NUVO RESEARCH
7.9 TECHFIELDS PHARMA
7.10 ASTELLAS PHARMA
7.11 HORIZON PHARMA
7.12 SANTOSOLVE
7.13 ENDO PHARMACEUTICALS HOLDINGS
7.14 BIODELIVERY SCIENCES INTERNATIONAL
7.15 ABBVIE
7.16 WINSTON PHARMACEUTICALS
7.17 ZYNERBA PHARMACEUTICALS
7.18 ICEUTICA
7.19 IROKO PHARMACEUTICALS
7.20 REGENERON PHARMACEUTICALS
7.21 PFIZER
7.22 DAIICHI SANKYO
7.23 JOHNSON & JOHNSON
7.24 ABBOTT LABORATORIES
7.25 YOOYOUNG PHARMACEUTICAL
7.26 CRYSTALGENOMICS
7.27 ABIOGEN PHARMA

CHAPTER 8: GLOBAL DRUGS FOR OSTEOARTHRITIS PAIN MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028

8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
  8.2.1 NSAIDs
  8.2.2 Opioids
  8.2.3 Viscosupplements
  8.2.4 Corticosteroids
  8.2.5 Others
8.3 Historic and Forecasted Market Size By Application
  8.3.1 Hospital
  8.3.2 Clinics
  8.3.3 Household

CHAPTER 9: NORTH AMERICA DRUGS FOR OSTEOARTHRITIS PAIN MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028

9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
  9.4.1 NSAIDs
  9.4.2 Opioids
  9.4.3 Viscosupplements
  9.4.4 Corticosteroids
  9.4.5 Others
9.5 Historic and Forecasted Market Size By Application
  9.5.1 Hospital
  9.5.2 Clinics
  9.5.3 Household
9.6 Historic and Forecast Market Size by Country
  9.6.1 U.S.
  9.6.2 Canada
  9.6.3 Mexico

CHAPTER 10: EUROPE DRUGS FOR OSTEOARTHRITIS PAIN MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028

10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
  10.4.1 NSAIDs
  10.4.2 Opioids
  10.4.3 Viscosupplements
  10.4.4 Corticosteroids
  10.4.5 Others
10.5 Historic and Forecasted Market Size By Application
  10.5.1 Hospital
  10.5.2 Clinics
  10.5.3 Household
10.6 Historic and Forecast Market Size by Country
  10.6.1 Germany
  10.6.2 U.K.
  10.6.3 France
  10.6.4 Italy
  10.6.5 Russia
  10.6.6 Spain
  10.6.7 Rest of Europe

CHAPTER 11: ASIA-PACIFIC DRUGS FOR OSTEOARTHRITIS PAIN MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028

11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
  11.4.1 NSAIDs
  11.4.2 Opioids
  11.4.3 Viscosupplements
  11.4.4 Corticosteroids
  11.4.5 Others
11.5 Historic and Forecasted Market Size By Application
  11.5.1 Hospital
  11.5.2 Clinics
  11.5.3 Household
11.6 Historic and Forecast Market Size by Country
  11.6.1 China
  11.6.2 India
  11.6.3 Japan
  11.6.4 Singapore
  11.6.5 Australia
  11.6.6 New Zealand
  11.6.7 Rest of APAC

CHAPTER 12: MIDDLE EAST & AFRICA DRUGS FOR OSTEOARTHRITIS PAIN MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028

12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
  12.4.1 NSAIDs
  12.4.2 Opioids
  12.4.3 Viscosupplements
  12.4.4 Corticosteroids
  12.4.5 Others
12.5 Historic and Forecasted Market Size By Application
  12.5.1 Hospital
  12.5.2 Clinics
  12.5.3 Household
12.6 Historic and Forecast Market Size by Country
  12.6.1 Turkey
  12.6.2 Saudi Arabia
  12.6.3 Iran
  12.6.4 UAE
  12.6.5 Africa
  12.6.6 Rest of MEA

CHAPTER 13: SOUTH AMERICA DRUGS FOR OSTEOARTHRITIS PAIN MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028

13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
  13.4.1 NSAIDs
  13.4.2 Opioids
  13.4.3 Viscosupplements
  13.4.4 Corticosteroids
  13.4.5 Others
13.5 Historic and Forecasted Market Size By Application
  13.5.1 Hospital
  13.5.2 Clinics
  13.5.3 Household
13.6 Historic and Forecast Market Size by Country
  13.6.1 Brazil
  13.6.2 Argentina
  13.6.3 Rest of SA

CHAPTER 14 INVESTMENT ANALYSIS

CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. DRUGS FOR OSTEOARTHRITIS PAIN MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. DRUGS FOR OSTEOARTHRITIS PAIN MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. DRUGS FOR OSTEOARTHRITIS PAIN MARKET COMPETITIVE RIVALRY
TABLE 005. DRUGS FOR OSTEOARTHRITIS PAIN MARKET THREAT OF NEW ENTRANTS
TABLE 006. DRUGS FOR OSTEOARTHRITIS PAIN MARKET THREAT OF SUBSTITUTES
TABLE 007. DRUGS FOR OSTEOARTHRITIS PAIN MARKET BY TYPE
TABLE 008. NSAIDS MARKET OVERVIEW (2016-2028)
TABLE 009. OPIOIDS MARKET OVERVIEW (2016-2028)
TABLE 010. VISCOSUPPLEMENTS MARKET OVERVIEW (2016-2028)
TABLE 011. CORTICOSTEROIDS MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 013. DRUGS FOR OSTEOARTHRITIS PAIN MARKET BY APPLICATION
TABLE 014. HOSPITAL MARKET OVERVIEW (2016-2028)
TABLE 015. CLINICS MARKET OVERVIEW (2016-2028)
TABLE 016. HOUSEHOLD MARKET OVERVIEW (2016-2028)
TABLE 017. NORTH AMERICA DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY TYPE (2016-2028)
TABLE 018. NORTH AMERICA DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY APPLICATION (2016-2028)
TABLE 019. N DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY COUNTRY (2016-2028)
TABLE 020. EUROPE DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY TYPE (2016-2028)
TABLE 021. EUROPE DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY APPLICATION (2016-2028)
TABLE 022. DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY COUNTRY (2016-2028)
TABLE 023. ASIA PACIFIC DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY TYPE (2016-2028)
TABLE 024. ASIA PACIFIC DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY APPLICATION (2016-2028)
TABLE 025. DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY COUNTRY (2016-2028)
TABLE 026. MIDDLE EAST & AFRICA DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY TYPE (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY APPLICATION (2016-2028)
TABLE 028. DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY COUNTRY (2016-2028)
TABLE 029. SOUTH AMERICA DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY TYPE (2016-2028)
TABLE 030. SOUTH AMERICA DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY APPLICATION (2016-2028)
TABLE 031. DRUGS FOR OSTEOARTHRITIS PAIN MARKET, BY COUNTRY (2016-2028)
TABLE 032. MERCK: SNAPSHOT
TABLE 033. MERCK: BUSINESS PERFORMANCE
TABLE 034. MERCK: PRODUCT PORTFOLIO
TABLE 035. MERCK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. CYTORI THERAPEUTICS: SNAPSHOT
TABLE 036. CYTORI THERAPEUTICS: BUSINESS PERFORMANCE
TABLE 037. CYTORI THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 038. CYTORI THERAPEUTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. ELI LILLY: SNAPSHOT
TABLE 039. ELI LILLY: BUSINESS PERFORMANCE
TABLE 040. ELI LILLY: PRODUCT PORTFOLIO
TABLE 041. ELI LILLY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. SANOFI: SNAPSHOT
TABLE 042. SANOFI: BUSINESS PERFORMANCE
TABLE 043. SANOFI: PRODUCT PORTFOLIO
TABLE 044. SANOFI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. NOVARTIS INTERNATIONAL: SNAPSHOT
TABLE 045. NOVARTIS INTERNATIONAL: BUSINESS PERFORMANCE
TABLE 046. NOVARTIS INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 047. NOVARTIS INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. AFFERENT PHARMACEUTICALS: SNAPSHOT
TABLE 048. AFFERENT PHARMACEUTICALS: BUSINESS PERFORMANCE
TABLE 049. AFFERENT PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 050. AFFERENT PHARMACEUTICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. NUVO RESEARCH: SNAPSHOT
TABLE 051. NUVO RESEARCH: BUSINESS PERFORMANCE
TABLE 052. NUVO RESEARCH: PRODUCT PORTFOLIO
TABLE 053. NUVO RESEARCH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. TECHFIELDS PHARMA: SNAPSHOT
TABLE 054. TECHFIELDS PHARMA: BUSINESS PERFORMANCE
TABLE 055. TECHFIELDS PHARMA: PRODUCT PORTFOLIO
TABLE 056. TECHFIELDS PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. ASTELLAS PHARMA: SNAPSHOT
TABLE 057. ASTELLAS PHARMA: BUSINESS PERFORMANCE
TABLE 058. ASTELLAS PHARMA: PRODUCT PORTFOLIO
TABLE 059. ASTELLAS PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. HORIZON PHARMA: SNAPSHOT
TABLE 060. HORIZON PHARMA: BUSINESS PERFORMANCE
TABLE 061. HORIZON PHARMA: PRODUCT PORTFOLIO
TABLE 062. HORIZON PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. SANTOSOLVE: SNAPSHOT
TABLE 063. SANTOSOLVE: BUSINESS PERFORMANCE
TABLE 064. SANTOSOLVE: PRODUCT PORTFOLIO
TABLE 065. SANTOSOLVE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. ENDO PHARMACEUTICALS HOLDINGS: SNAPSHOT
TABLE 066. ENDO PHARMACEUTICALS HOLDINGS: BUSINESS PERFORMANCE
TABLE 067. ENDO PHARMACEUTICALS HOLDINGS: PRODUCT PORTFOLIO
TABLE 068. ENDO PHARMACEUTICALS HOLDINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. BIODELIVERY SCIENCES INTERNATIONAL: SNAPSHOT
TABLE 069. BIODELIVERY SCIENCES INTERNATIONAL: BUSINESS PERFORMANCE
TABLE 070. BIODELIVERY SCIENCES INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 071. BIODELIVERY SCIENCES INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. ABBVIE: SNAPSHOT
TABLE 072. ABBVIE: BUSINESS PERFORMANCE
TABLE 073. ABBVIE: PRODUCT PORTFOLIO
TABLE 074. ABBVIE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. WINSTON PHARMACEUTICALS: SNAPSHOT
TABLE 075. WINSTON PHARMACEUTICALS: BUSINESS PERFORMANCE
TABLE 076. WINSTON PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 077. WINSTON PHARMACEUTICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 077. ZYNERBA PHARMACEUTICALS: SNAPSHOT
TABLE 078. ZYNERBA PHARMACEUTICALS: BUSINESS PERFORMANCE
TABLE 079. ZYNERBA PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 080. ZYNERBA PHARMACEUTICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 080. ICEUTICA: SNAPSHOT
TABLE 081. ICEUTICA: BUSINESS PERFORMANCE
TABLE 082. ICEUTICA: PRODUCT PORTFOLIO
TABLE 083. ICEUTICA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 083. IROKO PHARMACEUTICALS: SNAPSHOT
TABLE 084. IROKO PHARMACEUTICALS: BUSINESS PERFORMANCE
TABLE 085. IROKO PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 086. IROKO PHARMACEUTICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 086. REGENERON PHARMACEUTICALS: SNAPSHOT
TABLE 087. REGENERON PHARMACEUTICALS: BUSINESS PERFORMANCE
TABLE 088. REGENERON PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 089. REGENERON PHARMACEUTICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 089. PFIZER: SNAPSHOT
TABLE 090. PFIZER: BUSINESS PERFORMANCE
TABLE 091. PFIZER: PRODUCT PORTFOLIO
TABLE 092. PFIZER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 092. DAIICHI SANKYO: SNAPSHOT
TABLE 093. DAIICHI SANKYO: BUSINESS PERFORMANCE
TABLE 094. DAIICHI SANKYO: PRODUCT PORTFOLIO
TABLE 095. DAIICHI SANKYO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 095. JOHNSON & JOHNSON: SNAPSHOT
TABLE 096. JOHNSON & JOHNSON: BUSINESS PERFORMANCE
TABLE 097. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 098. JOHNSON & JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 098. ABBOTT LABORATORIES: SNAPSHOT
TABLE 099. ABBOTT LABORATORIES: BUSINESS PERFORMANCE
TABLE 100. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 101. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 101. YOOYOUNG PHARMACEUTICAL: SNAPSHOT
TABLE 102. YOOYOUNG PHARMACEUTICAL: BUSINESS PERFORMANCE
TABLE 103. YOOYOUNG PHARMACEUTICAL: PRODUCT PORTFOLIO
TABLE 104. YOOYOUNG PHARMACEUTICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. CRYSTALGENOMICS: SNAPSHOT
TABLE 105. CRYSTALGENOMICS: BUSINESS PERFORMANCE
TABLE 106. CRYSTALGENOMICS: PRODUCT PORTFOLIO
TABLE 107. CRYSTALGENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107. ABIOGEN PHARMA: SNAPSHOT
TABLE 108. ABIOGEN PHARMA: BUSINESS PERFORMANCE
TABLE 109. ABIOGEN PHARMA: PRODUCT PORTFOLIO
TABLE 110. ABIOGEN PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. DRUGS FOR OSTEOARTHRITIS PAIN MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. DRUGS FOR OSTEOARTHRITIS PAIN MARKET OVERVIEW BY TYPE
FIGURE 012. NSAIDS MARKET OVERVIEW (2016-2028)
FIGURE 013. OPIOIDS MARKET OVERVIEW (2016-2028)
FIGURE 014. VISCOSUPPLEMENTS MARKET OVERVIEW (2016-2028)
FIGURE 015. CORTICOSTEROIDS MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 017. DRUGS FOR OSTEOARTHRITIS PAIN MARKET OVERVIEW BY APPLICATION
FIGURE 018. HOSPITAL MARKET OVERVIEW (2016-2028)
FIGURE 019. CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 020. HOUSEHOLD MARKET OVERVIEW (2016-2028)
FIGURE 021. NORTH AMERICA DRUGS FOR OSTEOARTHRITIS PAIN MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. EUROPE DRUGS FOR OSTEOARTHRITIS PAIN MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. ASIA PACIFIC DRUGS FOR OSTEOARTHRITIS PAIN MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. MIDDLE EAST & AFRICA DRUGS FOR OSTEOARTHRITIS PAIN MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. SOUTH AMERICA DRUGS FOR OSTEOARTHRITIS PAIN MARKET OVERVIEW BY COUNTRY (2016-2028)


More Publications